Bionomics Ltd. is a clinical stage biopharmaceutical company, which discovers and develops therapeutics for cancer and diseases of the central nervous system. The company operates through following segments: Drug Discovery and Development, and Contract Services. The Drug discovery and development segment engages in the discovery, development and commercialization of compounds to match a target product profile. The Contract Services segment is the provision of scientific services on a fee for service basis to both external and internal customers. Its technology platforms include MultiCore, ionX, Angene and CSC Rx Discovery. Bionomics was founded in 1998 and is headquartered in Thebarton, Australia.